— Know what they know.
Not Investment Advice

GH NASDAQ

Guardant Health, Inc.
1W: +19.6% 1M: +31.8% 3M: +14.5% YTD: +16.0% 1Y: +195.2% 3Y: +323.1% 5Y: +7.5%
$118.95
+0.94 (+0.80%)
 
Weekly Expected Move ±6.0%
$84 $89 $95 $101 $106
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Buy · Power 71 · $15.8B mcap · 128M float · 1.58% daily turnover · Short 55% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
55.0 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -92.7%
Cost Advantage
45
Intangibles
59
Switching Cost
45
Network Effect
82
Scale
51
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. GH has a Narrow competitive edge (55.0/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. Negative ROIC of -92.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$127
Low
$131
Avg Target
$135
High
Based on 2 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 28Hold: 1Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$127.20
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-21 Piper Sandler $135 $127 -8 +6.4% $119.33
2026-05-12 Piper Sandler David Westenberg $130 $135 +5 +39.6% $96.71
2026-04-14 Barclays Luke Sergott $130 $115 -15 +39.9% $82.21
2026-02-24 Piper Sandler $90 $130 +40 +37.7% $94.42
2026-02-23 Raymond James Initiated $129 +32.3% $97.49
2026-02-20 Evercore ISI $105 $110 +5 +3.0% $106.84
2026-02-20 BTIG $140 $145 +5 +36.3% $106.38
2026-02-20 Stifel Nicolaus $120 $130 +10 +22.2% $106.38
2026-02-20 Canaccord Genuity $125 $135 +10 +26.9% $106.38
2026-02-20 Barclays $120 $130 +10 +22.2% $106.38
2026-02-17 Robert W. Baird Catherine Schulte Initiated $120 +14.4% $104.85
2026-01-30 UBS $110 $175 +65 +57.7% $111.00
2026-01-26 Guggenheim $115 $135 +20 +16.7% $115.69
2026-01-09 Stifel Nicolaus $70 $120 +50 +10.4% $108.74
2026-01-09 Mizuho Securities $120 $135 +15 +24.1% $108.74
2026-01-05 Guggenheim Subbu Nambi $36 $115 +79 +16.2% $99.00
2026-01-05 Evercore ISI Vijay Kumar Initiated $105 +3.2% $101.74
2025-12-22 Canaccord Genuity $100 $125 +25 +25.3% $99.74
2025-12-17 Mizuho Securities $100 $120 +20 +20.0% $100.00
2025-12-15 Leerink Partners Initiated $155 +49.0% $104.00
2025-12-15 Wells Fargo Brandon Couillard Initiated $120 +17.6% $102.04
2025-12-15 Barclays $85 $120 +35 +17.6% $102.04
2025-12-12 BTIG $100 $140 +40 +38.1% $101.34
2025-12-01 Morgan Stanley Tejas Savant $52 $130 +78 +23.6% $105.22
2025-10-30 UBS Dan Leonard $40 $110 +70 +15.4% $95.29
2025-10-30 BTIG Mark Massaro $80 $100 +20 +4.7% $95.55
2025-10-30 Mizuho Securities Bradley Bowers Initiated $100 +38.4% $72.27
2025-10-30 Canaccord Genuity Kyle Mikson $75 $100 +25 +38.4% $72.27
2025-10-30 Barclays $70 $85 +15 +17.6% $72.27
2025-10-22 Piper Sandler $40 $90 +50 +33.3% $67.51
2025-10-02 Barclays Initiated $70 +11.7% $62.65
2025-09-26 Canaccord Genuity Kyle Mikson $38 $75 +37 +24.6% $60.18
2025-09-25 Stifel Nicolaus $73 $70 -3 +16.3% $60.18
2025-09-25 BTIG Mark Massaro $50 $80 +30 +31.7% $60.75
2025-09-25 Stifel Nicolaus Daniel Arias Initiated $73 +16.5% $62.64
2025-09-25 Wolfe Research Doug Schenkel Initiated $75 +22.5% $61.23
2025-06-25 China Renaissance Securities (US) Inc. Tempus AI Initiated $70 +40.3% $49.90
2025-03-05 Morgan Stanley $80 $52 -28 +21.9% $42.66
2024-08-21 UBS Dan Leonard Initiated $40 +44.5% $27.68
2024-08-08 Craig-Hallum Bill Bonello $28 $37 +9 +18.0% $31.36
2024-08-08 Jefferies Tycho Peterson $32 $40 +8 +17.8% $33.96
2024-07-29 BTIG Mark Massaro $45 $50 +5 +41.7% $35.28
2024-06-28 Guggenheim Subbu Nambi Initiated $36 +24.7% $28.88
2024-06-04 Canaccord Genuity Kyle Mikson $30 $38 +8 +38.6% $27.41
2024-06-02 Jefferies Tycho Peterson Initiated $32 +18.1% $27.10
2024-05-23 BTIG Mark Massaro Initiated $45 +99.9% $22.51
2024-05-22 Canaccord Genuity Kyle Mikson $65 $30 -35 +30.4% $23.01
2024-04-24 Craig-Hallum Chase Knickerbocker Initiated $28 +56.1% $17.93
2023-09-27 Piper Sandler David Westenberg Initiated $40 +45.0% $27.59
2023-02-06 Goldman Sachs $80 $45 -35 +52.2% $29.56

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
3
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GH receives an overall rating of C+. Strongest factors: ROE (5/5). Areas of concern: ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

38 Grade D
Profitability
20
Balance Sheet
0
Earnings Quality
40
Growth
67
Value
32
Momentum
63
Safety
50
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GH scores highest in Growth (67/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.89
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.65
Unlikely Manipulator
Ohlson O-Score
-5.29
Bankruptcy prob: 0.5%
Low Risk
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
OCF/NI: 0.40x
Accruals: -14.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GH scores 1.89, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GH scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GH's score of -2.65 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GH's implied 0.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GH receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-36.05x
PEG
104.89x
P/S
14.60x
P/B
-86.24x
P/FCF
-53.93x
P/OCF
EV/EBITDA
-32.24x
EV/Revenue
11.67x
EV/EBIT
-29.32x
EV/FCF
-56.07x
Earnings Yield
-3.57%
FCF Yield
-1.85%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. GH currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.997
NI / EBT
×
Interest Burden
1.010
EBT / EBIT
×
EBIT Margin
-0.398
EBIT / Rev
×
Asset Turnover
0.617
Rev / Assets
×
Equity Multiplier
-14.644
Assets / Equity
=
ROE
362.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GH's ROE of 362.6% is driven by Asset Turnover (0.617), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$118.95
Median 1Y
$102.11
5th Pctile
$33.24
95th Pctile
$314.11
Ann. Volatility
65.4%
Analyst Target
$127.20
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Ines Dahne-Steuber Operating
ief Operating Officer
$307,101 $2,611,538 $5,836,716
Darya Chudova Technology
nology Officer
$424,462 $2,222,397 $4,755,541
Michael Bell Financial
ancial Officer
$482,000 $1,851,413 $4,123,993
Christopher Freeman Commercial
ercial Officer
$490,385 $1,621,395 $3,523,052
Craig Eagle Medical
edical Officer
$497,462 $1,565,107 $3,485,356
AmirAli Talasaz Co-Chief
Executive Officer
$1 $— $26,415
Helmy Eltoukhy Co-Chief
and Co-Chief Executive Officer
$1 $— $11,591

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $26,415
Avg Employee Cost (SGA/emp): $29,420
Employees: 24,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
24,000
+1087.5% YoY
Revenue / Employee
$40,918
Rev: $982,021,000
Profit / Employee
$-17,345
NI: $-416,277,000
SGA / Employee
$29,420
Avg labor cost proxy
R&D / Employee
$15,175
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -36.1% -39.0% -41.7% -43.1% -56.7% -62.3% -1.9% -1.9% -1.4% -1.2% -4.4% -4.2% -4.5% -4.7% -45.8% -43.8% -43.5% -41.9% 3.5% 3.6% 3.63%
ROA -23.4% -25.3% -18.1% -18.7% -24.6% -27.1% -34.3% -34.9% -26.6% -22.7% -28.2% -27.1% -28.9% -30.2% -26.7% -25.5% -25.3% -24.4% -23.8% -24.8% -24.76%
ROIC -81.8% -89.1% -29.9% -31.0% -33.4% -36.1% -1.0% -1.0% -1.0% -97.0% -1.3% -1.2% -1.2% -1.2% -98.3% -1.0% -1.0% -98.1% -90.5% -92.7% -92.66%
ROCE -16.5% -18.1% -19.0% -19.8% -26.3% -29.0% -45.9% -46.6% -35.6% -30.2% -30.1% -28.9% -30.9% -32.3% -34.3% -32.7% -32.5% -31.3% -24.2% -25.1% -25.13%
Gross Margin 67.5% 67.5% 69.1% 66.7% 66.3% 65.5% 62.9% 58.8% 60.7% 59.7% 1.5% 61.2% 59.1% 61.1% 61.6% 63.3% 65.0% 64.7% 64.6% 65.2% 65.22%
Operating Margin -1.1% -1.1% -90.8% -1.3% -1.2% -1.2% -1.2% -1.0% -87.2% -79.4% -1.3% -59.2% -56.8% -61.3% -62.4% -54.6% -45.9% -37.3% -43.0% -40.2% -40.23%
Net Margin -1.1% -1.1% -84.1% -1.3% -2.1% -1.4% -1.1% -1.0% -53.1% -60.2% -1.2% -68.2% -57.9% -56.3% -55.0% -46.8% -43.0% -35.0% -45.7% -37.2% -37.15%
EBITDA Margin -99.1% -1.1% -60.6% -1.2% -2.0% -1.3% -1.0% -95.0% -44.5% -51.7% -1.1% -61.3% -51.4% -50.4% -49.1% -41.2% -38.3% -31.0% -42.3% -33.5% -33.45%
FCF Margin -59.2% -72.4% -76.0% -79.1% -89.0% -90.0% -86.1% -86.6% -75.1% -67.8% -61.3% -49.8% -46.5% -39.6% -37.2% -39.4% -32.8% -29.1% -22.5% -20.8% -20.81%
OCF Margin -45.2% -55.6% -55.9% -56.6% -66.3% -68.6% -68.8% -73.7% -66.1% -62.9% -57.6% -46.5% -43.6% -36.7% -32.5% -35.2% -28.8% -24.7% -17.6% -16.2% -16.24%
ROA 3Y Avg snapshot only -25.12%
ROIC Economic snapshot only -22.64%
Cash ROA snapshot only -8.71%
Cash ROIC snapshot only -45.97%
CROIC snapshot only -58.92%
NOPAT Margin snapshot only -32.73%
Pretax Margin snapshot only -40.21%
R&D / Revenue snapshot only 33.95%
SGA / Revenue snapshot only 72.38%
SBC / Revenue snapshot only 12.30%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -33.18 -31.04 -25.07 -16.09 -7.47 -9.09 -4.26 -3.62 -7.66 -8.07 -6.69 -5.45 -7.21 -5.51 -8.66 -12.67 -15.61 -19.63 -31.57 -27.99 -36.046
P/S Ratio 38.82 36.87 27.22 17.25 10.09 12.78 6.20 4.99 7.64 6.51 5.68 4.16 5.49 4.08 5.12 6.82 7.79 8.67 13.38 11.23 14.602
P/B Ratio 9.68 9.76 15.77 10.46 6.38 8.54 46.33 39.99 64.73 57.99 20.20 15.82 22.28 17.79 -27.07 -37.79 -46.25 -56.06 -132.33 -122.10 -86.236
P/FCF -65.61 -50.93 -35.81 -21.80 -11.33 -14.20 -7.21 -5.76 -10.17 -9.60 -9.28 -8.35 -11.82 -10.29 -13.75 -17.31 -23.77 -29.86 -59.52 -53.93 -53.932
P/OCF
EV/EBITDA -33.84 -31.09 -29.50 -19.24 -9.08 -10.77 -5.12 -4.45 -9.18 -9.97 -7.83 -6.51 -8.37 -6.44 -10.96 -15.57 -18.88 -23.51 -36.43 -32.24 -32.244
EV/Revenue 35.92 34.14 28.40 18.38 11.17 13.81 7.00 5.73 8.34 7.18 6.01 4.47 5.78 4.35 5.79 7.46 8.39 9.22 13.87 11.67 11.670
EV/EBIT -32.01 -29.47 -27.79 -18.06 -8.61 -10.19 -4.83 -4.18 -8.44 -8.99 -7.12 -5.89 -7.63 -5.90 -9.89 -13.99 -16.98 -21.12 -32.93 -29.32 -29.323
EV/FCF -60.70 -47.15 -37.36 -23.22 -12.55 -15.34 -8.13 -6.62 -11.10 -10.59 -9.82 -8.97 -12.44 -10.96 -15.56 -18.94 -25.60 -31.75 -61.70 -56.07 -56.071
Earnings Yield -3.0% -3.2% -4.0% -6.2% -13.4% -11.0% -23.5% -27.6% -13.0% -12.4% -15.0% -18.4% -13.9% -18.2% -11.5% -7.9% -6.4% -5.1% -3.2% -3.6% -3.57%
FCF Yield -1.5% -2.0% -2.8% -4.6% -8.8% -7.0% -13.9% -17.4% -9.8% -10.4% -10.8% -12.0% -8.5% -9.7% -7.3% -5.8% -4.2% -3.3% -1.7% -1.9% -1.85%
PEG Ratio snapshot only 104.888
EV/Gross Profit snapshot only 17.983
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 28.27 28.27 5.72 5.72 5.72 5.72 6.17 6.17 6.17 6.17 6.54 6.54 6.54 6.54 4.68 4.68 4.68 4.68 4.84 4.84 4.843
Quick Ratio 27.93 27.93 5.57 5.57 5.57 5.57 5.90 5.90 5.90 5.90 6.24 6.24 6.24 6.24 4.36 4.36 4.36 4.36 4.56 4.56 4.559
Debt/Equity 0.66 0.66 2.13 2.13 2.13 2.13 22.75 22.75 22.75 22.75 8.53 8.53 8.53 8.53 -9.57 -9.57 -9.57 -9.57 -16.94 -16.94 -16.942
Net Debt/Equity -0.72 -0.72 0.68 0.68 0.68 0.68 5.95 5.95 5.95 5.95 1.17 1.17 1.17 1.17
Debt/Assets 0.38 0.38 0.62 0.62 0.62 0.62 0.85 0.85 0.85 0.85 0.76 0.76 0.76 0.76 0.90 0.90 0.90 0.90 0.84 0.84 0.836
Debt/EBITDA -2.49 -2.26 -3.82 -3.68 -2.74 -2.49 -2.23 -2.20 -2.96 -3.55 -3.12 -3.27 -3.05 -2.90 -3.43 -3.60 -3.63 -3.77 -4.50 -4.30 -4.303
Net Debt/EBITDA 2.74 2.49 -1.23 -1.18 -0.88 -0.80 -0.58 -0.58 -0.77 -0.93 -0.43 -0.45 -0.42 -0.40 -1.27 -1.34 -1.35 -1.40 -1.29 -1.23 -1.230
Interest Coverage -60.17 -59.71 -148.19 -154.52 -205.51 -226.65 -252.57 -256.47 -195.65 -166.06 -184.71 -177.38 -189.10 -197.52 -167.57 -151.32 -133.66 -117.27 -106.14 -96.55 -96.546
Equity Multiplier 1.75 1.75 3.42 3.42 3.42 3.42 26.75 26.75 26.75 26.75 11.26 11.26 11.26 11.26 -10.64 -10.64 -10.64 -10.64 -20.28 -20.28 -20.277
Cash Ratio snapshot only 3.969
Debt Service Coverage snapshot only -87.801
Cash to Debt snapshot only 0.714
FCF to Debt snapshot only -0.134
Defensive Interval snapshot only 425.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.20 0.21 0.17 0.17 0.18 0.19 0.24 0.25 0.27 0.28 0.33 0.36 0.38 0.41 0.45 0.47 0.51 0.55 0.56 0.62 0.617
Inventory Turnover 5.71 6.22 4.60 4.73 4.98 5.34 3.80 4.31 4.73 5.15 1.47 1.68 2.01 2.31 4.36 4.50 4.63 4.92 4.45 4.83 4.832
Receivables Turnover 6.39 6.79 4.95 5.18 5.41 5.71 4.61 4.95 5.23 5.50 6.23 6.67 7.11 7.64 7.75 8.12 8.69 9.46 8.03 8.83 8.829
Payables Turnover 9.20 10.02 5.36 5.50 5.80 6.22 2.91 3.30 3.62 3.94 1.38 1.59 1.89 2.17 6.42 6.63 6.82 7.25 7.51 8.16 8.156
DSO 57 54 74 70 67 64 79 74 70 66 59 55 51 48 47 45 42 39 45 41 41.3 days
DIO 64 59 79 77 73 68 96 85 77 71 248 217 181 158 84 81 79 74 82 76 75.5 days
DPO 40 36 68 66 63 59 125 111 101 93 264 230 193 168 57 55 53 50 49 45 44.8 days
Cash Conversion Cycle 81 76 85 81 78 74 50 48 46 45 43 41 40 38 74 71 67 62 79 72 72.1 days
Fixed Asset Turnover snapshot only 3.544
Operating Cycle snapshot only 116.9 days
Cash Velocity snapshot only 0.899
Capital Intensity snapshot only 1.864
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 25.6% 26.7% 30.3% 31.3% 26.1% 25.3% 20.3% 23.3% 25.0% 24.4% 25.5% 25.2% 26.2% 29.2% 31.0% 28.2% 28.7% 30.4% 32.9% 39.6% 39.56%
Net Income -2.1% -1.2% -59.8% -24.9% -45.5% -48.2% -61.4% -58.6% 7.8% 28.6% 26.8% 30.7% 3.4% -18.5% 9.0% 9.6% 15.7% 22.2% 4.6% -4.0% -4.00%
EPS -2.0% -1.2% -57.2% -23.8% -44.3% -47.0% -60.1% -57.3% 13.5% 38.0% 36.6% 41.5% 14.2% -13.4% 12.8% 11.2% 16.8% 23.6% 8.2% 1.9% 1.87%
FCF -62.1% -93.1% -79.8% -1.2% -89.7% -55.8% -36.2% -34.9% -5.5% 6.3% 10.7% 28.0% 21.9% 24.5% 20.4% -1.4% 9.2% 4.4% 19.7% 26.3% 26.25%
EBITDA -2.5% -1.4% -62.3% -26.1% -46.1% -46.2% -71.0% -66.5% 7.7% 30.1% 29.5% 33.4% 4.1% -21.0% 10.0% 10.5% 17.1% 24.2% 4.1% -5.5% -5.48%
Op. Income -1.8% -1.1% -61.2% -30.1% -23.8% -22.9% -32.5% -30.2% -18.6% -3.4% -3.7% 4.5% 6.1% -0.4% 21.4% 14.2% 9.9% 14.1% 1.4% 1.6% 1.63%
OCF Growth snapshot only 35.58%
Asset Growth snapshot only 35.54%
Debt Growth snapshot only 25.93%
Shares Change snapshot only 5.98%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.2% 77.8% 48.9% 32.7% 28.0% 25.3% 25.6% 25.5% 25.3% 26.6% 25.8% 26.3% 25.5% 25.6% 26.6% 28.0% 29.8% 30.9% 30.85%
Revenue 5Y 76.6% 54.1% 39.1% 30.3% 28.1% 25.8% 26.3% 27.2% 27.9% 29.4% 29.39%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 1.4% 84.7% 51.5% 33.3% 26.8% 22.1% 21.9% 20.5% 35.3% 37.1% 35.0% 35.4% 21.5% 21.5% 23.7% 25.9% 29.2% 32.0% 32.01%
Gross Profit 5Y 91.0% 64.6% 46.2% 35.8% 25.6% 23.2% 24.5% 25.4% 26.7% 28.9% 28.89%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 55.4% 55.4% 55.4% 55.4% 18.7% 18.7% 18.7% 18.7% -7.7% -7.7% -7.7% -7.7% -12.3% -12.3% -12.3% -12.3% 7.7% 7.7% 7.74%
Assets 5Y 24.9% 24.9% 24.9% 24.9% 9.1% 9.1% 9.1% 9.1% -2.4% -2.4% -2.38%
Equity 3Y 10.1% 10.1% 10.1% 10.1% -57.8% -57.8% -57.8% -57.8% -50.4% -50.4% -50.4% -50.4%
Book Value 3Y 3.4% 4.0% 5.2% 6.8% -59.0% -58.9% -59.5% -60.1% -53.1% -53.4% -53.4% -53.5%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.96 1.00 0.95 0.94 0.98 1.00 1.00 0.99 0.99 0.99 0.99 1.00 1.00 0.98 0.96 0.96 0.96 0.95 0.94 0.93 0.927
Earnings Stability 0.88 0.96 0.96 0.91 0.95 0.98 0.96 0.95 0.88 0.72 0.84 0.78 0.78 0.69 0.54 0.42 0.37 0.21 0.09 0.02 0.018
Margin Stability 0.97 0.98 0.92 0.95 0.98 0.98 0.98 0.97 0.96 0.95 0.85 0.86 0.88 0.89 0.86 0.87 0.88 0.88 0.86 0.86 0.864
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 1.00 1.00 1.00 0.50 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.90 0.82 0.81 0.50 0.50 0.97 0.89 0.89 0.88 0.99 0.93 0.96 0.96 0.94 0.91 0.98 0.98 0.984
Earnings Smoothness
ROE Trend -0.15 -0.12 -0.48 -0.47 -0.63 -0.67 -10.46 -10.59 -7.87 -6.56 2.73 2.94 1.56 0.83
Gross Margin Trend 0.01 -0.01 -0.00 0.01 0.00 -0.00 -0.02 -0.04 -0.05 -0.06 0.19 0.19 0.18 0.17 -0.14 -0.12 -0.09 -0.07 -0.09 -0.08 -0.079
FCF Margin Trend -0.15 -0.32 -0.33 -0.34 -0.36 -0.30 -0.21 -0.23 -0.01 0.13 0.20 0.33 0.36 0.39 0.36 0.29 0.28 0.25 0.27 0.24 0.238
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.39 0.47 0.52 0.53 0.49 0.49 0.47 0.53 0.66 0.78 0.68 0.61 0.57 0.50 0.55 0.65 0.58 0.56 0.41 0.40 0.405
FCF/OCF 1.31 1.30 1.36 1.40 1.34 1.31 1.25 1.18 1.14 1.08 1.06 1.07 1.07 1.08 1.15 1.12 1.14 1.18 1.28 1.28 1.282
FCF/Net Income snapshot only 0.519
CapEx/Revenue 14.0% 16.8% 20.1% 22.5% 22.7% 21.4% 17.2% 12.9% 9.0% 4.9% 3.6% 3.3% 2.9% 2.9% 4.7% 4.2% 4.0% 4.4% 4.9% 4.6% 4.58%
CapEx/Depreciation snapshot only 1.269
Accruals Ratio -0.14 -0.13 -0.09 -0.09 -0.13 -0.14 -0.18 -0.16 -0.09 -0.05 -0.09 -0.11 -0.12 -0.15 -0.12 -0.09 -0.11 -0.11 -0.14 -0.15 -0.147
Sloan Accruals snapshot only 0.169
Cash Flow Adequacy snapshot only -3.549
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.9% 0.7% 0.6% 0.3% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2.8% -3.6% -2.6% -3.2% 0.0% 0.9% 0.6% 0.4% -2.4% -3.0% -3.04%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2.8% -3.6% -2.6% -3.2% 0.0% 0.9% 0.6% 0.4% -2.4% -3.0% -3.04%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.03 1.01 1.06 1.05 1.04 1.03 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.997
Interest Burden (EBT/EBIT) 1.02 1.02 1.01 1.01 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.010
EBIT Margin -1.12 -1.16 -1.02 -1.02 -1.30 -1.36 -1.45 -1.37 -0.99 -0.80 -0.84 -0.76 -0.76 -0.74 -0.59 -0.53 -0.49 -0.44 -0.42 -0.40 -0.398
Asset Turnover 0.20 0.21 0.17 0.17 0.18 0.19 0.24 0.25 0.27 0.28 0.33 0.36 0.38 0.41 0.45 0.47 0.51 0.55 0.56 0.62 0.617
Equity Multiplier 1.54 1.54 2.30 2.30 2.30 2.30 5.41 5.41 5.41 5.41 15.52 15.52 15.52 15.52 171.88 171.88 171.88 171.88 -14.64 -14.64 -14.644
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-3.74 $-4.03 $-3.99 $-4.12 $-5.40 $-5.92 $-6.39 $-6.48 $-4.67 $-3.67 $-4.05 $-3.79 $-4.01 $-4.16 $-3.53 $-3.36 $-3.33 $-3.18 $-3.24 $-3.30 $-3.30
Book Value/Share $12.83 $12.80 $6.34 $6.33 $6.32 $6.31 $0.59 $0.59 $0.55 $0.51 $1.34 $1.30 $1.30 $1.29 $-1.13 $-1.13 $-1.13 $-1.11 $-0.77 $-0.76 $-1.38
Tangible Book/Share $12.64 $12.61 $6.17 $6.16 $6.15 $6.13 $0.44 $0.44 $0.42 $0.38 $1.24 $1.20 $1.20 $1.19 $-1.21 $-1.21 $-1.21 $-1.19 $-1.57 $-1.54 $-1.54
Revenue/Share $3.20 $3.39 $3.67 $3.84 $4.00 $4.21 $4.39 $4.70 $4.69 $4.55 $4.76 $4.96 $5.26 $5.63 $5.97 $6.25 $6.68 $7.20 $7.63 $8.23 $8.23
FCF/Share $-1.89 $-2.45 $-2.79 $-3.04 $-3.56 $-3.79 $-3.77 $-4.07 $-3.52 $-3.09 $-2.92 $-2.47 $-2.44 $-2.23 $-2.22 $-2.46 $-2.19 $-2.09 $-1.72 $-1.71 $-1.71
OCF/Share $-1.44 $-1.89 $-2.06 $-2.17 $-2.65 $-2.89 $-3.02 $-3.46 $-3.10 $-2.86 $-2.74 $-2.31 $-2.29 $-2.06 $-1.94 $-2.20 $-1.92 $-1.78 $-1.34 $-1.34 $-1.34
Cash/Share $17.74 $17.70 $9.17 $9.16 $9.14 $9.12 $9.86 $9.85 $9.29 $8.59 $9.86 $9.60 $9.54 $9.50 $6.79 $6.78 $6.77 $6.70 $9.34 $9.15 $8.40
EBITDA/Share $-3.40 $-3.72 $-3.54 $-3.67 $-4.92 $-5.40 $-6.00 $-6.06 $-4.26 $-3.28 $-3.66 $-3.40 $-3.63 $-3.79 $-3.15 $-2.99 $-2.97 $-2.83 $-2.91 $-2.98 $-2.98
Debt/Share $8.45 $8.43 $13.51 $13.49 $13.46 $13.43 $13.36 $13.34 $12.58 $11.63 $11.42 $11.12 $11.06 $11.00 $10.80 $10.79 $10.76 $10.66 $13.08 $12.82 $12.82
Net Debt/Share $-9.29 $-9.27 $4.34 $4.33 $4.32 $4.31 $3.49 $3.49 $3.29 $3.04 $1.56 $1.52 $1.51 $1.50 $4.01 $4.00 $4.00 $3.96 $3.74 $3.66 $3.66
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.886
Altman Z-Prime snapshot only 3.533
Piotroski F-Score 4 3 3 3 2 2 3 3 3 4 6 6 5 5 3 4 4 4 6 6 6
Beneish M-Score -2.88 -2.80 -1.52 -1.51 -1.68 -1.74 -3.89 -3.68 -3.32 -3.10 -2.92 -2.66 -2.72 -2.89 -2.03 -2.68 -2.79 -2.73 -2.64 -2.65 -2.651
Ohlson O-Score snapshot only -5.285
Net-Net WC snapshot only $-4.93
EVA snapshot only $-391725830.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 57.04 57.69 48.05 39.65 28.98 35.08 23.31 22.80 27.07 26.90 22.45 22.63 22.59 22.54 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 41
Sector Credit Rank snapshot only 36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms